Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥90% predicted at baseline
Structured Surveillance of Achromobacter, Pandoraea and Ralstonia Species From Patients in England With Cystic Fibrosis
Pseudomonas Aeruginosa Antibody Response in Cystic Fibrosis Decreases Rapidly Following Lung Transplantation
Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls
Developing a smartphone application to support social connectedness and wellbeing in young people with cystic fibrosis
Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy
